Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.70 billion. The enterprise value is $11.69 billion.
Important Dates
The last earnings date was Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | Feb 24, 2025 |
Share Statistics
Organon & Co. has 257.54 million shares outstanding. The number of shares has increased by 1.12% in one year.
| Current Share Class | 257.54M |
| Shares Outstanding | 257.54M |
| Shares Change (YoY) | +1.12% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 82.28% |
| Float | 256.58M |
Valuation Ratios
The trailing PE ratio is 4.31 and the forward PE ratio is 3.69. Organon & Co.'s PEG ratio is 1.61.
| PE Ratio | 4.31 |
| Forward PE | 3.69 |
| PS Ratio | 0.60 |
| Forward PS | 0.59 |
| PB Ratio | 7.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.61 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 13.53 |
| EV / Sales | 1.83 |
| EV / EBITDA | 5.92 |
| EV / EBIT | 6.85 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 17.75 |
| Debt / EBITDA | 4.43 |
| Debt / FCF | n/a |
| Interest Coverage | 3.28 |
Financial Efficiency
Return on equity (ROE) is 408.51% and return on invested capital (ROIC) is 11.79%.
| Return on Equity (ROE) | 408.51% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.79% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $640,300 |
| Profits Per Employee | $86,400 |
| Employee Count | 10,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -57.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.28% in the last 52 weeks. The beta is 0.72, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -18.28% |
| 50-Day Moving Average | 15.35 |
| 200-Day Moving Average | 18.31 |
| Relative Strength Index (RSI) | 41.30 |
| Average Volume (20 Days) | 3,398,803 |
Short Selling Information
The latest short interest is 18.45 million, so 7.16% of the outstanding shares have been sold short.
| Short Interest | 18.45M |
| Short Previous Month | 18.23M |
| Short % of Shares Out | 7.16% |
| Short % of Float | 7.19% |
| Short Ratio (days to cover) | 6.76 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.40 billion and earned $864.00 million in profits. Earnings per share was $3.33.
| Revenue | 6.40B |
| Gross Profit | 3.81B |
| Operating Income | 1.71B |
| Pretax Income | 655.00M |
| Net Income | 864.00M |
| EBITDA | 1.97B |
| EBIT | 1.71B |
| Earnings Per Share (EPS) | $3.33 |
Full Income StatementBalance Sheet
The company has $763.00 million in cash and $8.75 billion in debt, giving a net cash position of -$7.99 billion or -$31.01 per share.
| Cash & Cash Equivalents | 763.00M |
| Total Debt | 8.75B |
| Net Cash | -7.99B |
| Net Cash Per Share | -$31.01 |
| Equity (Book Value) | 493.00M |
| Book Value Per Share | 1.91 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 59.50%, with operating and profit margins of 26.68% and 13.49%.
| Gross Margin | 59.50% |
| Operating Margin | 26.68% |
| Pretax Margin | 12.60% |
| Profit Margin | 13.49% |
| EBITDA Margin | 30.84% |
| EBIT Margin | 26.67% |
| FCF Margin | n/a |